Novais Teddy, Duclos Antoine, Varin Remi, Lopez Isabelle, Chamouard Valérie
Int J Clin Pharm. 2016 Feb;38(1):61-9. doi: 10.1007/s11096-015-0207-z.
Replacement therapy in haemophilia plays an important role in the effective management of this rare bleeding disorder and requires a high level of knowledge and practical skills.
To evaluate and to compare the knowledge and skills about the medicines and their management among people with haemophilia treated with clotting factor concentrates, and their informal caregivers.
Eight Hospital Pharmacies working closely with Haemophilia Care Centres in France. Method In this cross-sectional and multi-centre study, 26-item questionnaire was specifically developed to assess the knowledge and skills. Face-to-face interviews using a questionnaire were conducted with patients and caregivers.
Level of knowledge and skills about disease, treatment and medication management. Results This study included 80 patients and 55 caregivers. Although most interviewees had basic knowledge of the treatment, only 43.7 % knew the effect of clotting factor concentrates on the haemostasis process. Similarly, only 12.7 % of the patients and 30.9 % of the caregivers referred to inhibitors as adverse effects. Despite intensive training for home treatment, 55.7 % reported difficulties with reconstitution or injection. The knowledge required for the responsible management of their medications had not been totally acquired: only 17 participants were indeed familiar with the medication storage conditions; 29 patients and 9 caregivers had already experienced an emergency which they had to treat with no medicine available at home; and 47.4 % of participants had already thrown away an unused drug vial.
This study shows the need of a regular update and to renew awareness of haemophilia treatment specificities among these populations. The identified needs suggest that we should more invest in educational techniques or therapeutic education programs more focused on medication management.
血友病的替代疗法在这种罕见出血性疾病的有效管理中发挥着重要作用,并且需要高水平的知识和实践技能。
评估并比较接受凝血因子浓缩物治疗的血友病患者及其非正式照料者关于药物及其管理的知识和技能。
与法国血友病护理中心密切合作的八家医院药房。方法在这项横断面多中心研究中,专门设计了一份包含26个条目的问卷来评估知识和技能。使用问卷对患者和照料者进行面对面访谈。
关于疾病、治疗和药物管理的知识和技能水平。结果本研究纳入了80名患者和55名照料者。尽管大多数受访者对治疗有基本了解,但只有43.7%的人知道凝血因子浓缩物对止血过程的作用。同样,只有12.7%的患者和30.9%的照料者提到抑制剂是不良反应。尽管接受了家庭治疗的强化培训,但55.7%的人报告在复溶或注射方面有困难。他们尚未完全掌握药物合理管理所需的知识:只有17名参与者确实熟悉药物储存条件;29名患者和9名照料者曾经历过紧急情况,而家中没有可用药物来处理;47.4%的参与者已经扔掉过未使用的药瓶。
本研究表明这些人群需要定期更新并重新认识血友病治疗的特殊性。所确定的需求表明我们应该在更侧重于药物管理的教育技术或治疗教育项目上加大投入。